Epidemiology of lung cancer: A general update

European Respiratory Review

Volumn 12, Issue 84, 2002, Pages 112-121

  Nackaerts, K ^a   Axelson, O ^b   Brambilla, E ^c   Bromen, K ^d   Hirsch, F R ^e   Nemery, B ^a   Petit, M R ^a   Sasco, A J ^f   Van Meerbeeck, J ^g   Van Zandwijk, N ^h   Demedts, M ⁱ   Diederich, S ⁱ   Huber, R M ⁱ   Ninane, V ⁱ   Leo, F ⁱ   Spiro, S ⁱ   Thiberville, L ⁱ  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b LINKÖPING UNIVERSITY   (Sweden)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h NETHERLANDS CANCER INSTITUTE   (Netherlands)

ⁱ NONE

Author keywords

Asbestos; Epidemiology; Genetic susceptibility; Lung cancer; Nutrition; Smoking

Indexed keywords

ASBESTOS; CARCINOGEN; ENVIRONMENTAL CHEMICAL; RADON;

CANCER GENETICS; CANCER INCIDENCE; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; GENETIC EPIDEMIOLOGY; HUMAN; LUNG CANCER; NUTRITION; OCCUPATIONAL HAZARD; PASSIVE SMOKING; PATHOLOGY; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0037737730     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (119)

1. Olsen JH. Epidemiology of lung cancer. Eur Respir Mon 1995; 1: 1-17.
2. Schottenfeld D. Etiology and epidemiology of lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, eds. Lung cancer: Principles and Practice. Philadelphia, Lippincott Williams and Wilkins, 2000; pp. 367-388.
3. McKean-Cowdin R, Spencer Feigelson H, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s. J Clin Oncol 2000; 18: 2258-2268.
4. Boyle P, Gandini S, Gray N. Epidemiology of lung cancer: a century of great success and ignominious failure. In: Hansen HH, ed. Textbook of Lung Cancer. London, Martin Dunitz, 2000; pp. 13-25.
5. Lange P, Vestbo J. Lung cancer. Eur Respir Mon 2000; 15: 92-104.
6. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93: 824-842.
7. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease. Lancet 1997; 349: 1498-1504.
8. Doll R. Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis 1999; 3: 90-99.
9. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000; 18: 2309-2315.
10. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-1107.
11. Levi F, Lucchini F, La Vecchia C, Negri E. Trends in mortality from cancer in the European Union, 1955-94. Lancet 1999; 354: 742-743.
12. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000. Cancer incidence, mortality and prevalence worldwide. Lyon, International Agency for Research on Cancer Press, 2001.
13. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88: 183-192.
14. Shriver SP, Bourdeau HA, Gubish CT, et al. Sexspecific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000; 92: 24-33.
15. Nordlund LA, Carstensen JM, Pershagen G. Are male and female smokers at equal risk of smoking-related cancer: evidence from a Swedish prospective study. Scand J Public Health 1999; 27: 56-62.
16. Ries LAG, Kosary CL, Hankey BF, et al. SEER cancer statistics review: 1973-1994. NIH Publication No. 97-2789. Bethesda, National Cancer Institute, 1997.
17. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993; 22: 592-599.
18. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341: 1198-1205.
19. Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkenan GP. Impact of race in lung cancer. Analysis of temporal trends from a surveillance, epidemiology and end results database. Chest 2001; 120: 55-63.
20. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Lung cancer in young patients: analysis of a surveillance, epidemiology, and end results database. J Clin Oncol 1998; 16: 651-657.
21. Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of adenocarcinoma. Int J Epidemiol 1997; 26: 14-23.
22. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol 1999; 10: Suppl. 5, S3-S6.
23. Friberg L, Cederlof R. Late effects of air pollution with special reference to lung cancer. Environ Health Perspect 1978; 22: 45-66.
24. Pershagen G. Air pollution and cancer. In: Vainio H, Sorsa M, Michael AJ, eds. Complex Mixtures and Cancer Risk. IARC Mon 1990; 104: 240-251.
25. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Tobacco smoking. Volume 38. Lyon, IARC, 1986.
26. Rigdon RH, Kirchoff, H. Cancer of the lung from 1900 to 1930. Surg Gynec Obstet 1958; 107: 105-118.
27. Fleckseder R. Ueber den bronchialkrebs und einige seiner entstehungsbedingungen. [About the pathogenesis of lung cancer]. Munch Med Wochenschr 1936; 36: 1585-1593.
28. Müller FH. Tabaksmißbrauch und lungenkarzinom. [Tobacco abuse and lung cancer]. Z Krebsforsch 1939; 49: 57-85.
29. Ochsner A, Debakey M. Primary pulmonary malignancy. Treatment by total pneumonectomy. Analysis of 79 collected cases and presentation of 7 personal cases. Surg Gynecol Obstet 1939; 68: 435-451.
30. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. JAMA 1950; 10: 329-336.
31. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. BMJ 1952; ii: 1271-1286.
32. van Zandwijk N. Aetiology and prevention of lung cancer. Eur Respir Mon 1995; 1: 18-49.
33. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976; ii: 1525-1536.
34. Samet JM. The epidemiology of lung cancer. Chest 1993; 103: 20S-29S.
35. US Public Health Services. Smoking and health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. US Dept of Health, Education and Welfare, Public Health Service, DHEW Publication 1103. Washington, Center for Disease Control, 1964.
36. Hauptmann M, Lubin JH, Rosenberg P, Wellmann J, Kreienbrock L. The use of sliding time windows for the exploratory analysis of temporal effects of smoking histories on lung cancer risk. Stat Med 2000; 19: 2185-2194.
37. Wilcox HB, Schoenberg JB, Mason TJ, Bill JS, Stemhagen A. Smoking and lung cancer: risk as a function of cigarette tar content. Prev Med 1988; 17: 263-272.
38. Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340: 1773-1780.
39. Boffetta P, Pershagen G, Jockel KH, et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 1999; 91: 697-701.
40. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Relation of the type of tobacco and inhalation pattern to pulmonary and total mortality. Eur Respir J 1992; 5: 1111-1117.
41. Carriot F, Sasco AJ. Cannabis and cancer. Rev Epidemiol Sante Publique 2000; 48: 473-483.
42. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993; 85: 457-464.
43. Jaakola MS. Environmental tobacco smoke and respiratory diseases. Eur Respir Mon 2000; 15: 322-383.
44. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ Clin Res Ed 1981; 282: 183-185.
45. Trichopoulos D, Kalandidi A, Sparros L, MacMahon B. Lung cancer and passive smoking. Int J Cancer 1981; 27: 1-4.
46. Jöckel KH. Gesundheitsrisiken durch passivrauchen. [Health risks of passive smoking]. Deutsches Ärzteblatt 2000; 43: B2417-B2422.
47. Zhong L, Goldberg MS, Parent M-E, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000; 27: 3-18.
48. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-988.
49. Boffetta P, Agudo A, Ahrens W, Benhamou E, Benhamou S. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440-1450.
50. Jockel KH, Ahrens W, Jahn I, Pohlabeln H, Bolm-Audorff U. Occupational risk factors for lung cancer: a case-control study in West Germany. Int J Epidemiol 1998; 27: 549-560.
51. Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987; 9: 175-193.
52. Coultas DB, Samet JM. Occupational lung cancer. Clin Chest Med 1992; 13: 341-354.
53. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci 1979; 330: 473-490.
54. Pershagen G, Akerblom G, Axelson O, et al. Residential radon exposure and lung cancer in Sweden. N Engl J Med 1994; 330: 159-164.
55. BEIR IV. Committee of Biological Effects of Ionizing Radiations, US National Research Council. Health risks of radon and other internally deposited alpha-emitters. Washington, National Academy Press, 1988.
56. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1192-1208.
57. Pastorino U, Berrino F, Gervasion A, Pesenti V, Riboli E, Crosignani P. Proportion of lung cancer due to occupation. Int J Cancer 1984; 33: 231-237.
58. Damber L, Larsson G. Occupation and male lung cancer: a case-control study in northern Sweden. Br J Ind Med 1987; 44: 446-453.
59. Kjuus H, Langard S, Skaerven R. A case-reference study of lung cancer, occupational exposures and smoking. Etiologic fraction of occupational exposures. Scand J Environ Health 1986; 12: 210-215.
60. Dave SK, Edling C, Jacobsson P, Axelson O. Occupation, smoking and lung cancer. Br J Ind Med 1988; 45: 790-792.
61. Kvale G, Bjelke E, Heuch I. Occupational exposure and lung cancer risk. Int J Cancer 1986; 37: 185-193.
62. Ronco G, Ciccone G, Mirabelli D, Troia B, Vineis P. Occupation and lung cancer in two industrialized areas of northern Italy. Int J Cancer 1988; 41: 354-358.
63. Dreyer L, Andersen A, Pukkala E. Avoidable cancers in the Nordic countries. Occupation. APMIS 1997; 76: 68-79.
64. Nurminen M, Karjalainen A. Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand J Work Environ Health 2001; 27: 161-213.
65. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs. Volumes 1-42. Supplement 7. Lyon, IARC, 1987.
66. Baan R. International Agency for Research on Cancer. http://monographs.iarc.fr. Date accessed: June 6 2002.
67. Landrigan PJ. Asbestos - still a carcinogen. N Engl J Med 1998; 338: 1618-1619.
68. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 1998; 338: 1565-1571.
69. Härting FH, Hesse W. Der lungenkrebs, die bergkrankheit in den Schneeberger gruben. [Lung cancer, a mountain sickness in the Schneeberger mines]. Vierteljahrsschr Gerichtl Med Offentl Gesundheitswesen 1879.
70. Axelson O. Occupational and environmental exposure to radon: cancer risks. Annu Rev Public Health 1991; 12: 235-255.
71. Axelson O. Cancer risks from exposure to radon in homes. Environ Health Perspect 1995; 103: Suppl. 2, 37-43.
72. Auvinen A, Makelainen I, Hakama M, et al. Indoor radon exposure and risk of lung cancer: a nested casecontrol study in Finland. J Natl Cancer Inst 1996; 88: 966-972.
73. Darby S, Whitley E, Silcocks P, Thakrar B, Green M. Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer 1998; 78: 394-408.
74. Alavanja MC, Lubin JH, Mahaffey JA, Brownson RC. Residential radon exposure and risk of lung cancer in Missouri. Am J Public Health 1999; 89: 1042-1048.
75. Kreienbrock L, Kreuzer M, Gerken M, et al. Casecontrol study on lung cancer and residential radon in western Germany. Am J Epidemiol 2001; 153: 42-52.
76. Letourneau EG, Krewski D, Choi NW, et al. Casecontrol study of residential radon and lung cancer in Winnipeg, Manitoba, Canada. Am J Epidemiol 1994; 140: 310-322.
77. Alavanja MC, Brownson RC, Lubin JH, et al. Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst 1994; 86: 1829-1837.
78. Lubin JH, Boice JD. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 1997; 89: 49-57.
79. Lubin JH, Tomasek L, Edling C, et al. Estimating lung cancer mortality from residential radon using data for low exposures of miners. Radiat Res 1997; 147: 126-134.
80. Doll R, Vessey MP, Beasley RWR, et al. Mortality of gasworkers - final report of a prospective study. Br J Ind Med 1972; 29: 394-406.
81. Lloyd JW. Long-term mortality study of steelworkers. V. Respiratory cancer in coke plant workers. J Occup Med 1971; 13: 53-68.
82. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds. Part 3. Industrial exposures in aluminium production, coal gasification, coke production, and iron and steel founding. Volume 34. Lyon, IARC, 1984.
83. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. Diesel and gasoline engine exhausts and some nitroarenes. Volume 46. Lyon, IARC, 1989.
84. Seow A, Poh W-T, Teh M, et al. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2000; 9: 1215-1221.
85. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-41.
86. Axelsson G, Liljeqvist T, Andersson L, Bergman B, Rylander R. Dietary factors and lung cancer among men in west Sweden. Int J Epidemiol 1996; 25: 32-39.
87. Menkes MS, Comstock GW, Vuillemier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986; 315: 1250-1254.
88. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention Cancer Study Group. JAMA 1996; 276: 1957-1963.
89. Fujiki H, Suganuma M, Okabe S, et al. Cancer prevention with green tea and monitoring by a new marker, hn RNP B1. Mutat Res 2001; 480/481: 299-304.
90. Zhang L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shangai, China. Epidemiology 2001; 12: 695-700.
91. Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metabol Rev 2000; 32: 395-411.
92. Spitz MR, Duphorne CM, Detry MA, et al. Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione-S-transferase polymorphisms in lung cancer risk in current smokers. Cancer Epidemiol Biomarkers Prev 2000; 9: 1017-1020.
93. Zhang J, Temme E, Kesteloot H. Fish consumption is inversely associated with male lung cancer mortality in countries with high levels of cigarette smoking or animal fat consumption. Int J Epidemiol 2000; 29: 615-621.
94. Goodman MT, Hankin JH, Wilkens LR, Kolonel LN. High-fat foods and the risk of lung cancer. Epidemiology 1992; 3: 288-299.
95. Mettlin C. Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer 1989; 43: 608-612.
96. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997; 6: 540-549.
97. Darby S, Whitley E, Doll R, Key T, Silcocks P. Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England. Br J Cancer 2001; 84: 728-735.
98. Feskanich D, Ziegler RG, Michaud DS, Giovannucci EL, Speizer FE. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92: 1812-1823.
99. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health 1987; 77: 425-431.
100. Schwartz AG. Genetic susceptibility to lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, eds. Lung Cancer: Principles and Practice. Philadelphia, Lippincott Williams and Wilkins, 2000; pp. 389-397.
101. Petersen GM. Familial aggregation: sorting susceptibility from shared environment. J Natl Cancer Inst 2000; 92: 1114-1115.
102. Haugen A. Etiology of lung cancer. In: Hansen HH, ed. Textbook of Lung Cancer. London, Martin Dunitz, 2000; pp. 1-12.
103. Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jöckel K-H. Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 2000; 152: 497-505.
104. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996; 144: 554-562.
105. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Elston GZ. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990; 82: 1272-1279.
106. Gauderman WJ, Morrison JL, Carpenter CL, Thomas DC. Analysis of gene-smoking interaction in lung cancer. Genet Epidemiol 1997; 14: 199-214.
107. Davidson BJ, Hsu TC, Schantz SP. The genetics of tobacco-induced malignancy. Arch Otolaryngol Head Neck Surg 1993; 119: 1198-1205.
108. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 1999; 107; Suppl. 1, 37-47.
109. Wei Q, Cheng L, Amos CI, Wang L, Guo Z. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764-1772.
110. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210.
111. Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 1999; 118: 1136-1152.
112. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarker Prev 1995; 4: 589-594.
113. Bennett WP, Alavanja MCR, Blomeke B, Vähäkangas H, Castrén K. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999; 91: 2009-2014.
114. Benhamou S, Reinikainen M, Bouchardy C, Dager P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998; 58: 5291-5293.
115. Zhou W, Thurston SW, Liu G, et al. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 461-466.
116. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 1354-1357.
117. Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M. Association of CYP1A1 germline polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 1996; 56: 72-76.
118. US Dept of Health and Human Services. The health consequences of smoking: nicotine addiction. A report of the Surgeon General. Atlanta, GA, US Dept of Health and Human Services. DHHS Publication No. (PHS) (CDC) 888406. Public Health Service, Center for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, 1988.
119. Wu X, Suchanek Hudmon K, Detry MA, et al. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9: 1021-1026.